课题基金 / 基金详情

Evaluation of Blood Product Utilization, Healthcare Resource Consumption and Patient Outcomes in New Oral Anticoagulant-Related Hemorrhage.

Evaluation of Blood Product Utilization, Healthcare Resource Consumption and Patient Outcomes in New Oral Anticoagulant-Related Hemorrhage.
新型口服抗凝剂相关出血的血液制品利用、医疗资源消耗和患者预后的评估。
批准号：
275406
负责人：
Johnson Ana
金额：
$22.19万
依托单位：
Queen's University (Kingston, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-09-01 至 2015-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=275406&lang=en
关键词：
Adverse Effects Anticoagulation Atrial Fibrillation Health Care Utilization Knowledge Translation Population Cohort Stroke Prevention

项目摘要

项目成果

Johnson Ana的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Atrial fibrillation is a heart condition that increases the chance of stroke in elderly individuals, and this can be prevented through anticoagulation, or blood-thinning. Too much blood-thinning, however, can lead to bleeding and death. Recently, two new
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluation of Health Links in the South East Local Health Integration Network
海外基金